Results 231 to 240 of about 790,096 (261)
Some of the next articles are maybe not open access.
Biosimilars Pharmaceutical Market in India: Current Status, Challenges and Future Perspective
Bioscience Biotechnology Research Communications, 2021openaire +1 more source
P & T : a peer-reviewed journal for formulary management, 2014
Unlike a generic drug, a "generic" biologic won't be identical to the branded product. Manufacturers are divided over whether pharmacists should have to tell doctors when they prescribe one of the "biosimilars" that will soon appear on the market.
openaire +1 more source
Unlike a generic drug, a "generic" biologic won't be identical to the branded product. Manufacturers are divided over whether pharmacists should have to tell doctors when they prescribe one of the "biosimilars" that will soon appear on the market.
openaire +1 more source
Healthcare system conversion to a biosimilar: Trials and tribulations.
American Journal of Health-System Pharmacy, 2021exaly